szmtag Infarction-related cardiogenic shock—diagnosis, monitoring and therapy (12.02.2021)
DÄ internationalArchive6/2021Infarction-related cardiogenic shock—diagnosis, monitoring and therapy

Clinical Practice Guideline

Infarction-related cardiogenic shock—diagnosis, monitoring and therapy

A German-Austrian S3 guideline

Dtsch Arztebl Int 2021; 118: 88-95. DOI: 10.3238/arztebl.m2021.0012

Werdan, K; Buerke, M; Geppert, A; Thiele, H; Zwissler, B; Ruß, M

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

* Leitliniengruppe siehe eKasten 1
Universitätsklinik und Poliklinik für Innere Medizin III, Universitätsklinikum Halle (Saale) der Martin-Luther-
Universität Halle-Wittenberg: Prof. Dr. med. Karl Werdan
Klinik für Kardiologie, Angiologie und internistische Intensivmedizin, St. Marien Krankenhaus Siegen: Prof. Dr. med.
Michael Buerke
Abteilung für
Kardiologie, Klinik Ottakring, Wiener Gesundheitsverbund, Wien: Univ.-Doz. Dr. med. Alexander Geppert
Universitätsklinik für Kardiologie, Herzzentrum Leipzig: Prof. Dr. med. Holger Thiele
Klinik für Anaesthesiologie, LMU Klinikum, München: Prof. Dr. med. Bernd Zwissler
Internisten am Maxplatz, Traunstein/Belegkardiologie Traunstein: Dr. med. Martin Ruß
1.Scholz KH, Maier SKG, Maier LS, et al.: Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J 2018; 39: 1065–74 CrossRef MEDLINE PubMed Central
2.Werdan K, Ruß M, Buerke M, Delle-Karth G, Geppert A, Schöndube FA: Cardiogenic shock due to myocardial infarction: diagnosis, monitoring and treatment. A German-Austrian S3 guideline. Dtsch Arztebl Int 2012; 109: 343–51 CrossRef MEDLINE PubMed Central
3.Zeymer U, Bueno H, Granger CB, et al.: Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of the European Society of Cardiology. EHJ Acute Cardiovasc Care 2020; 9: 183–97 CrossRef MEDLINE
4.Werdan K, Ruß M, Boeken U, et al: Infarkt-bedingter kardiogener Schock – Diagnose, Monitoring und Therapie. S3-Leitlinie. AWMF-RN 019–013. AWMF 2019. https://www.awmf.org/leitlinien/detail/ll/019-013.html (last accessed on 28 December 2020).
5.Thiele H, Ohman EM, de Waha-Thiele S, et al.: Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J 2019; 40: 2671–83 CrossRef MEDLINE
6.Bangalore S, Gupta N, Guo Y, et al.: Outcomes with invasive vs. conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med 2015; 128: 601–8 CrossRef MEDLINE
7.Thiele H, Akin I, Sandri M, et al.: PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 2017; 377: 2419–32 CrossRef MEDLINE
8.White HD, Assmann SF, Sanborn TA, et al.: Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the should we emergently revascularize occluded coronaries for cardiogenic shock (SHOCK) trial. Circulation 2005; 112: 1992–2001 CrossRef MEDLINE
9.Zeymer U, Hochadel M, Karcher A-K, et al.: Procedural success rates and mortality in elderly patients with percutaneous coronary intervention for cardiogenic shock. JACC Cardiovasc Interv 2019; 12: 1853–9 CrossRef MEDLINE
10.Thiele H, Zeymer U, Neumann F-J, et al., for the IABP-SHOCK II Trial Investigators: Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287–96 CrossRef MEDLINE
11.Zeymer U, Schneider S, Zahn R, et al.: Impact of pre-hospital resuscitation on short- and long-term mortality in patients with cardiogenic shock undergoing revascularization: results of IABP-SHOCK study. J Am Coll Cardiol 2018; 71 (11 Suppl): 198 Presentation Number 1262–456 CrossRef
12.Michels G, Wengenmayer T, Hagl C, et al.: Empfehlungen zur extrakorporalen kardiopulmonalen Reanimation (eCPR): Konsensuspapier der DGIIN, DGK, DGTHG, DGfK, DGNI, DGAI, DIVI und GRC. Med Klin Intensivmed Notfmed 2018; 113: 478–86 CrossRef MEDLINE
13.Pichler P, Antretter H, Dünser M, et al.: Positionspapier der Österreichischen Kardiologischen Gesellschaft zum Einsatz der extrakorporalen Membranoxygenation (ECMO) bei Erwachsenen kardiologischen Patienten. Wien Klin Wochenschr 2015; 127: 169–84 CrossRef MEDLINE
14.Levy B, Clere-Jehl R, Legras A, et al.: Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 2018; 72: 173–82 CrossRef MEDLINE
15.Prondzinsky R, Lemm H, Swyter M, et al.: Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38: 152–60 CrossRef MEDLINE
16.Prondzinsky R, Unverzagt S, Russ M, et al.: Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK trial. Shock 2012; 37: 378–84 CrossRef MEDLINE
17.Unverzagt S, Buerke M, de Waha A, et al.: Intra-aortic balloon pump counter-pulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev 2015; 3: CD007398 CrossRef MEDLINE
18.Schrage B, Ibrahim K, Loehn T, et al.: Impella support for acute myocardial infarction complicated by cardiogenic shock: a matched-pair IABP-SHOCK II trial 30-day mortality analysis. Circulation 2019; 139: 1249–58 CrossRef MEDLINE
19.Thiele H, Jobs A, Ouweneel DM, et al.: Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J 2017; 38: 3523–31 CrossRef MEDLINE
20.Tramm R, Ilic D, Davies AR, et al.: Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database Syst Rev 2015; 1: CD010381 CrossRef MEDLINE PubMed Central
21.Ouweneel DM, Schotborgh JV, Limpens J, et al.: Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis. Intensive Care Med 2016; 42: 1922–34 CrossRef MEDLINE PubMed Central
22.Formica F, Mariani S, D’Alessanmdro S: Acute mechanical complications in patients suffering from acute myocardial infarction. Vessels Plus 2019; 3: 37 CrossRef
23.Schlotter F, de Waha S, Eitel I, et al.: Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence. EuroIntervention 2016; 12: 94–102 CrossRef MEDLINE
24.Adamzik M, Bauer A, Bein T, et al.: Invasive Beatmung und Einsatz extrakorporaler Verfahren bei akuter respiratorischer Insuffizienz. S3-Leitlinie. AWMF-RN 001/021. 1th edition. Stand 05.12.2017. www.awmf.org/uploads/tx_szleitlinien/001-021l_S3_Invasive_Beatmung_2017-12.pdf (last accessed on 30 December 2020).
25.Guo L, Wang W, Zhao N, et al.: Mechanical ventilation strategies for intensive care unit patients without acute lung injury or acute respiratory distress syndrome: a systematic review and network meta-analysis. Crit Care 2016; 20: 226 CrossRef MEDLINE PubMed Central
26.Simonis G, Steiding K, Schaefer K, et al.: A prospective, randomized trial of continuous lateral rotation (”kinetic therapy”) in patients with cardiogenic shock. Clin Res Cardiol 2012; 101: 955–62 CrossRefMEDLINE
27.Dres M, Teboul JL, Monnet X: Weaning the cardiac patient from mechanical ventilation. Curr Opin Crit Care 2014; 20: 493–8 CrossRef MEDLINE
28.Lauridsen MD, Gammelager H, Schmidt M, et al.: Acute kidney injury treated with renal replacement therapy and 5-year mortality after myocardial infarction-related cardiogenic shock: a nationwide population-based cohort study. Crit Care 2015; 19: 452 CrossRef MEDLINE PubMed Central
29.Barilla F, Pannarale G, Torromeo C, et al.: Ivabradine in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a preliminary randomized prospective study. Clin Drug Investig 2016; 36: 849–56 CrossRef MEDLINE
30.Bjarnason-Wehrens B, Held K, Hoberg E, et al.: Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha). Clin Res Cardiol Supplements 2007; 2: III/1-III/54. Aktualisierung: S3–Leitlinie zur kardiologischen Rehabilitation (LL-KardReha) im deutschsprachigen Raum Europas. Deutschland, Österreich, Schweiz (D-A-CH), Langversion – Teil 1, 2019 AWMF-RN: 133/001, www.awmf.org/uploads/tx_szleitlinien/133-001k_S3-Kardiologische-Rehabilitation-in-D-A-CH_2020-12.pdf (last accessed on 12 December 2020) CrossRef
31.Thiele H, Zeymer U, Thelemann N, et al.: Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial. Circulation 2019; 139: 395–403 CrossRef MEDLINE
32.Karagiannidis C, Windisch W: Epidemiologie und Mortalität der Herz- und Lungenersatzverfahren in Deutschland zwischen 2007 und 2014. (Letter). Med Klin Intensivmed Notfmed 2016; 111: 556–9 CrossRef MEDLINE
33.Van Diepen S, Hochman JS, Stebbins A, et al.: Association between delays in mechanical ventilation initiation and mortality in patients with refractory cardiogenic shock. JAMA Cardiol 2020; 5: 965– CrossRef MEDLINE
34.Schneck M, Hoder K, Gielen S, et al.: Lung protective ventilation and hospital survival of cardiac intensive care patients. Med Klin Intensivmed Notfmed 2016; 111: 508–13 CrossRef MEDLINE
35.Reintam Blaser A, Malbrain ML, Starkopf J, et al.: Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems. Intensive Care Med 2012; 38: 384–94 CrossRef MEDLINE PubMed Central
36.Werdan K, Boeken U, Briegel J, et al.: Infarktbedingter kardiogener Schock – Diagnose, Monitoring und Therapie. S3-Leitlinie. Intensiv- und Notfallbehandlung 2021; 46, in print.
37.Reignier J, Boisramé-Helms J, Brisard L, et al.: Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2). Lancet 2018; 391: 133–43 CrossRef
38.Heyland D, Muscedere J, Wischmeyer PE, et al.: A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013; 368: 1489–97 CrossRef MEDLINE
39.The PEPTIC Investigators for the Australian and New Zealnad Intensive Care Society Clinical Trials Group. Alberta Health Services Critical Care Strategic Clinical Network, and the Irish Critical Care Trials Group: Effect of stress ulcer prophylaxis with proton pump inhibitors vs histamine-2 receptor blockers on in-hospital mortality among ICU patients receiving invasive mechanical ventilation. The PEPTIC Randomized Clinical Trial. JAMA 2020; 323: 616–26 CrossRef MEDLINE PubMed Central